Bloodwork question about exemestane. Baseline, a fortnight in, and the numbers moved in a direction I did not expect.
The effect size I actually noticed is roughly a third of what the write-ups imply, and it took a fortnight to be sure.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
Loose evidence is not the same as no evidence and people overcorrect in both directions.
Would like a narrow answer rather than an enthusiastic one.
Sterility is the part people wave through and it is the part that actually bites.
Baseline first.
Cold storage, light protection, date on the vial. Boring, removes half the variables.
Is a baseline blood test really necessary before starting something like this?
Narrow conclusion.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison. Not on exemestane but the pattern is familiar.
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing.
Read methods.
What is the first thing you would read if you were starting from zero? Side effects was my main issue with exemestane too.
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing.
Stupid question: how do you know whether what is in the vial matches the label at all?
Stupid question: how do you know whether what is in the vial matches the label at all?